trial, a multicenter study of chest pain evaluation in which patients were randomized to early CCTA compared with standard optimal care after hsTn had ruled out MI in the ED. The trial was composed of 500 patients, with a mean age of 54 years, who had presented with low-to intermediate-risk acute chest pain and were followed for 30 days. As expected, there was no difference in mortality (with only 1 death overall) or in major adverse cardiac events. As a result of power issues, the primary endpoint of the trial was the need for coronary revascularization. There was a 2% excess of procedures in the CCTA arm (9% vs. 7%, p ¼ 0.40), but the investigators had powered the trial to detect a 9% absolute difference in revascularization rates between the 2 arms if CCTA was to be considered superior. There were also no differences in the pre-specified key secondary outcome measures of discharge from the ED, length of stay, and repeat ED visits. The only clear advantage of CCTA appeared to be in the reduction of costs of about 34% due to significant reductions in outpatient testing after the index ED visit. In the hsTn era, we anticipate that such surrogate outcomes of efficiency of care and optimal use of resources will become increasingly important.
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Another important issue is the long-term management of patients beyond the first 30 days. In one randomized comparison with standard exercise stress testing, CCTA was associated with both reduced ED visits and cardiac admissions (7), whereas in another, there was no difference (8 
